MD | DC | VA
Our Goal: To become a Top 3 BioHealth Hub by 2023.
Driving Innovation and Entrepreneurship
- World–renowned research institutions and universities
- Influential policymakers and advocacy groups pioneering new health strategies
- World–leading infectious disease research and vaccine development
- Fastest growing region for healthcare companies in the U.S.
- Rated #1 in the nation for science and engineering talent
- Mission control for the National Cancer Moonshot Initiative
Founding Partners
A non-exclusive collaboration between NanoCellect and QIAGEN aims to accelerate adoption and ease of use of single-cell RNAseq by combining the power of NanoCellect’s WOLF® Cell Sorter with QIAGEN’s QIAseq®…
QIAGEN N.V. QGEN recently announced that it has inked an agreement with McKesson Medical-Surgical Inc. Mckesson Corporation’s MCK affiliate will serve as the exclusive distributor of QIAGEN’s QIAstat-Dx syndromic testing…
Last week two new partnerships were formed between Maryland and the United Kingdom. Biohealth Innovation, a MD based public-private nonprofit focused on accelerating commercialization for biohealth, will be collaborating with Catalyze, an…
Meeting on HepTcell Phase 2 program for treatment of chronic hepatitis B (HBV) GAITHERSBURG, Md., June 10, 2019 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced…
GAITHERSBURG, Md., June 03, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract award by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and…
Steven Kafka, the former Foundation Medicine chief operating officer who landed at Third Rock Ventures after a globetrotting “gap year,” has a new gig: CEO of Thrive Earlier Detection, a liquid…